Otsuka Holdings Co., Ltd. (OTSKF)

Market Cap	24.62B
Revenue (ttm)	14.82B
Net Income (ttm)	2.18B
Shares Out	n/a
EPS (ttm)	4.03
PE Ratio	11.28
Forward PE	n/a
Dividend	0.81 (1.69%)
Ex-Dividend Date	Dec 27, 2024

Volume	100
Average Volume	213
Open	47.80
Previous Close	47.80
Day's Range	47.80 - 47.80
52-Week Range	39.48 - 66.15
Beta	0.20
RSI	72.83
Earnings Date	Apr 30, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKF

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY